Global Immunohistochemistry (IHC) Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

September 2026 | 109 pages | ID: GFAD46382E60EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Immunohistochemistry (IHC) Services market size was valued at US$ 960 million in 2025 and is forecast to a readjusted size of US$ 1453 million by 2032 with a CAGR of 6.1% during review period.

Immunohistochemistry (IHC) Services refer to specialized biological analysis services that use antibody-based detection technologies to identify and visualize specific proteins, biomarkers, and molecular targets within tissue samples. These services typically involve tissue preparation, fixation, embedding, sectioning, antigen retrieval, immunostaining, imaging analysis, and pathological interpretation to support biomedical research, drug discovery, clinical diagnostics, and translational medicine. This research focuses on commercial Immunohistochemistry (IHC) Services that provide customized tissue staining, biomarker evaluation, spatial protein expression analysis, and related analytical solutions for pharmaceutical companies, biotechnology organizations, research institutions, and healthcare applications.

Key Findings

  • Immunohistochemistry (IHC) Services enable biomarker detection and tissue-based molecular analysis
  • IHC services are widely applied in drug discovery and pathological research workflows
  • Pharmaceutical and biotechnology companies represent important customer groups for IHC services
  • North America and Europe remain major regions for advanced IHC service adoption
  • Multiplex staining and digital pathology technologies enhance IHC analytical capabilities

Market Trends

The development of Immunohistochemistry (IHC) Services is moving from conventional single-marker staining toward more advanced, quantitative, and multi-dimensional tissue analysis solutions. Increasing demand for precision medicine, biomarker-driven drug development, and translational research is driving service providers to integrate multiplex immunohistochemistry, automated staining platforms, digital pathology, and image analysis technologies. The industry is gradually shifting from standardized staining services toward customized analytical solutions capable of supporting complex biological interpretation and pharmaceutical research requirements.

Market Dynamics

Drivers

Growing investment in oncology research, precision medicine, companion diagnostics, and biologics development is driving demand for Immunohistochemistry (IHC) Services. Pharmaceutical and biotechnology companies increasingly require reliable tissue-based biomarker analysis to support target validation, clinical research, and therapeutic development decisions.

Restraints

The Immunohistochemistry (IHC) Services market faces limitations related to technical complexity, variability in tissue samples, antibody performance differences, and the need for highly skilled interpretation. Maintaining consistent quality across different projects and ensuring standardized analytical workflows remain important challenges for service providers.

Opportunities

Expansion of personalized medicine, biomarker discovery, spatial biology research, and advanced cancer diagnostics creates new opportunities for IHC service providers. The combination of multiplex technologies, artificial intelligence-assisted image analysis, and digital pathology platforms is expected to broaden the application scope and improve analytical efficiency.

Challenges

The industry faces challenges related to regulatory requirements, technology standardization, data interpretation complexity, and increasing competition from emerging molecular analysis technologies. Service providers need to continuously improve technical capabilities and develop integrated solutions to maintain competitiveness in a rapidly evolving biomedical research environment.

Industry Chain Analysis

The industry chain of Immunohistochemistry (IHC) Services includes upstream antibody reagents, tissue processing materials, staining instruments, imaging equipment, and analytical software technologies. The midstream segment focuses on professional service providers delivering tissue preparation, immunostaining, biomarker analysis, digital imaging, and interpretation services. The downstream market consists of pharmaceutical companies, biotechnology companies, academic research institutions, hospitals, and diagnostic organizations applying IHC results in drug development, disease research, and clinical applications. The value creation process mainly depends on technical expertise, assay reliability, analytical accuracy, and the ability to provide customized solutions for specific research and diagnostic requirements.

Segment Insights

The Immunohistochemistry (IHC) Services market can be segmented by service type, technology approach, and application area. Standard immunohistochemistry remains a fundamental service category, while multiplex immunohistochemistry and advanced digital analysis solutions represent important growth directions due to increasing demand for deeper biological characterization. Oncology research represents one of the major application areas, supported by the importance of tissue biomarkers in cancer diagnosis, therapeutic selection, and drug development. Service providers with capabilities in customized assay development, quantitative image analysis, and integrated pathological interpretation are gaining stronger market opportunities.

Downstream Market Opportunities

The downstream opportunities for Immunohistochemistry (IHC) Services are mainly concentrated in pharmaceutical research, biotechnology development, clinical diagnostics, academic studies, and translational medicine. Drug developers increasingly rely on IHC analysis for biomarker validation, mechanism studies, clinical trial support, and companion diagnostic development. Growing demand for precision healthcare and targeted therapies continues to expand the need for specialized tissue analysis services with higher accuracy and efficiency.

Regional Insights

North America represents a major market for Immunohistochemistry (IHC) Services due to its advanced biotechnology ecosystem, strong pharmaceutical research activities, and extensive clinical development infrastructure. Europe also maintains an important position supported by established biomedical research capabilities and pharmaceutical innovation activities. Asia Pacific is becoming an increasingly important growth region driven by expanding biotechnology investment, increasing research capacity, and rising demand for advanced biomedical testing services. Regional market differences mainly reflect variations in healthcare infrastructure, research funding, regulatory environment, and pharmaceutical development activity.

Competitive Landscape Analysis

The competitive landscape of Immunohistochemistry (IHC) Services is characterized by specialized life science service providers, contract research organizations, pathology service companies, and integrated biomedical analysis platforms. Competition is mainly based on technical expertise, assay development capability, analytical accuracy, turnaround efficiency, and the ability to support complex research projects. Companies with comprehensive service portfolios covering tissue processing, staining optimization, digital pathology, and data interpretation are better positioned to meet pharmaceutical and biotechnology customer requirements. Strategic integration of advanced imaging technologies and analytical platforms is becoming an important direction for enhancing service differentiation.

Report Scope

This report is a detailed and comprehensive analysis for global Immunohistochemistry (IHC) Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Immunohistochemistry (IHC) Services market size and forecasts, in consumption value ($ Million), 2021-2032

Global Immunohistochemistry (IHC) Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032

Global Immunohistochemistry (IHC) Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032

Global Immunohistochemistry (IHC) Services market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Immunohistochemistry (IHC) Services
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Immunohistochemistry (IHC) Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River Laboratories, Labcorp Drug Development, IQVIA, ICON plc, Eurofins Scientific, Thermo Fisher Scientific, Bio-Techne, NeoGenomics Laboratories, HistoCyte Laboratories, Histowiz, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Immunohistochemistry (IHC) Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Market segment by Type

  • Biomarker Detection IHC Services
  • Protein Expression Analysis IHC Services
  • Tumor Tissue IHC Services
  • Normal Tissue IHC Services
  • Animal Model Tissue IHC Services

Market segment by Scale

  • Small-Scale IHC Service (<50 Slides)
  • Medium-Scale IHC Service (50–500 Slides)
  • Large-Scale IHC Service (>500 Slides)

Market segment by Application

  • Drug Discovery Research
  • Oncology Research
  • Clinical Biomarker Validation
  • Pathology Diagnosis
  • Toxicology Studies
  • Others

Market segment by players, this report covers

  • Charles River Laboratories
  • Labcorp Drug Development
  • IQVIA
  • ICON plc
  • Eurofins Scientific
  • Thermo Fisher Scientific
  • Bio-Techne
  • NeoGenomics Laboratories
  • HistoCyte Laboratories
  • Histowiz
  • WuXi AppTec
  • Provitro
  • NICHIREI BIOSCIENCES INC.
  • Samsung Biologics

Market segment by regions, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
  • South America (Brazil, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Chapter Outline

Chapter 1, to describe Immunohistochemistry (IHC) Services product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Immunohistochemistry (IHC) Services, with revenue, gross margin, and global market share of Immunohistochemistry (IHC) Services from 2021 to 2026.

Chapter 3, the Immunohistochemistry (IHC) Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Immunohistochemistry (IHC) Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Immunohistochemistry (IHC) Services.

Chapter 13, to describe Immunohistochemistry (IHC) Services research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immunohistochemistry (IHC) Services by Type
  1.3.1 Overview: Global Immunohistochemistry (IHC) Services Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Immunohistochemistry (IHC) Services Consumption Value Market Share by Type in 2025
  1.3.3 Biomarker Detection IHC Services
  1.3.4 Protein Expression Analysis IHC Services
  1.3.5 Tumor Tissue IHC Services
  1.3.6 Normal Tissue IHC Services
  1.3.7 Animal Model Tissue IHC Services
1.4 Classification of Immunohistochemistry (IHC) Services by Scale
  1.4.1 Overview: Global Immunohistochemistry (IHC) Services Market Size by Scale: 2021 Versus 2025 Versus 2032
  1.4.2 Global Immunohistochemistry (IHC) Services Consumption Value Market Share by Scale in 2025
  1.4.3 Small-Scale IHC Service (<50 Slides)
  1.4.4 Medium-Scale IHC Service (50–500 Slides)
  1.4.5 Large-Scale IHC Service (>500 Slides)
1.5 Global Immunohistochemistry (IHC) Services Market by Application
  1.5.1 Overview: Global Immunohistochemistry (IHC) Services Market Size by Application: 2021 Versus 2025 Versus 2032
  1.5.2 Drug Discovery Research
  1.5.3 Oncology Research
  1.5.4 Clinical Biomarker Validation
  1.5.5 Pathology Diagnosis
  1.5.6 Toxicology Studies
  1.5.7 Others
1.6 Global Immunohistochemistry (IHC) Services Market Size & Forecast
1.7 Global Immunohistochemistry (IHC) Services Market Size and Forecast by Region
  1.7.1 Global Immunohistochemistry (IHC) Services Market Size by Region: 2021 VS 2025 VS 2032
  1.7.2 Global Immunohistochemistry (IHC) Services Market Size by Region, (2021-2032)
  1.7.3 North America Immunohistochemistry (IHC) Services Market Size and Prospect (2021-2032)
  1.7.4 Europe Immunohistochemistry (IHC) Services Market Size and Prospect (2021-2032)
  1.7.5 Asia-Pacific Immunohistochemistry (IHC) Services Market Size and Prospect (2021-2032)
  1.7.6 South America Immunohistochemistry (IHC) Services Market Size and Prospect (2021-2032)
  1.7.7 Middle East & Africa Immunohistochemistry (IHC) Services Market Size and Prospect (2021-2032)

2 COMPANY PROFILES

2.1 Charles River Laboratories
  2.1.1 Charles River Laboratories Details
  2.1.2 Charles River Laboratories Major Business
  2.1.3 Charles River Laboratories Immunohistochemistry (IHC) Services Product and Solutions
  2.1.4 Charles River Laboratories Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Charles River Laboratories Recent Developments and Future Plans
2.2 Labcorp Drug Development
  2.2.1 Labcorp Drug Development Details
  2.2.2 Labcorp Drug Development Major Business
  2.2.3 Labcorp Drug Development Immunohistochemistry (IHC) Services Product and Solutions
  2.2.4 Labcorp Drug Development Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 Labcorp Drug Development Recent Developments and Future Plans
2.3 IQVIA
  2.3.1 IQVIA Details
  2.3.2 IQVIA Major Business
  2.3.3 IQVIA Immunohistochemistry (IHC) Services Product and Solutions
  2.3.4 IQVIA Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 IQVIA Recent Developments and Future Plans
2.4 ICON plc
  2.4.1 ICON plc Details
  2.4.2 ICON plc Major Business
  2.4.3 ICON plc Immunohistochemistry (IHC) Services Product and Solutions
  2.4.4 ICON plc Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 ICON plc Recent Developments and Future Plans
2.5 Eurofins Scientific
  2.5.1 Eurofins Scientific Details
  2.5.2 Eurofins Scientific Major Business
  2.5.3 Eurofins Scientific Immunohistochemistry (IHC) Services Product and Solutions
  2.5.4 Eurofins Scientific Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Eurofins Scientific Recent Developments and Future Plans
2.6 Thermo Fisher Scientific
  2.6.1 Thermo Fisher Scientific Details
  2.6.2 Thermo Fisher Scientific Major Business
  2.6.3 Thermo Fisher Scientific Immunohistochemistry (IHC) Services Product and Solutions
  2.6.4 Thermo Fisher Scientific Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.7 Bio-Techne
  2.7.1 Bio-Techne Details
  2.7.2 Bio-Techne Major Business
  2.7.3 Bio-Techne Immunohistochemistry (IHC) Services Product and Solutions
  2.7.4 Bio-Techne Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Bio-Techne Recent Developments and Future Plans
2.8 NeoGenomics Laboratories
  2.8.1 NeoGenomics Laboratories Details
  2.8.2 NeoGenomics Laboratories Major Business
  2.8.3 NeoGenomics Laboratories Immunohistochemistry (IHC) Services Product and Solutions
  2.8.4 NeoGenomics Laboratories Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.9 HistoCyte Laboratories
  2.9.1 HistoCyte Laboratories Details
  2.9.2 HistoCyte Laboratories Major Business
  2.9.3 HistoCyte Laboratories Immunohistochemistry (IHC) Services Product and Solutions
  2.9.4 HistoCyte Laboratories Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 HistoCyte Laboratories Recent Developments and Future Plans
2.10 Histowiz
  2.10.1 Histowiz Details
  2.10.2 Histowiz Major Business
  2.10.3 Histowiz Immunohistochemistry (IHC) Services Product and Solutions
  2.10.4 Histowiz Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 Histowiz Recent Developments and Future Plans
2.11 WuXi AppTec
  2.11.1 WuXi AppTec Details
  2.11.2 WuXi AppTec Major Business
  2.11.3 WuXi AppTec Immunohistochemistry (IHC) Services Product and Solutions
  2.11.4 WuXi AppTec Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 WuXi AppTec Recent Developments and Future Plans
2.12 Provitro
  2.12.1 Provitro Details
  2.12.2 Provitro Major Business
  2.12.3 Provitro Immunohistochemistry (IHC) Services Product and Solutions
  2.12.4 Provitro Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 Provitro Recent Developments and Future Plans
2.13 NICHIREI BIOSCIENCES INC.
  2.13.1 NICHIREI BIOSCIENCES INC. Details
  2.13.2 NICHIREI BIOSCIENCES INC. Major Business
  2.13.3 NICHIREI BIOSCIENCES INC. Immunohistochemistry (IHC) Services Product and Solutions
  2.13.4 NICHIREI BIOSCIENCES INC. Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 NICHIREI BIOSCIENCES INC. Recent Developments and Future Plans
2.14 Samsung Biologics
  2.14.1 Samsung Biologics Details
  2.14.2 Samsung Biologics Major Business
  2.14.3 Samsung Biologics Immunohistochemistry (IHC) Services Product and Solutions
  2.14.4 Samsung Biologics Immunohistochemistry (IHC) Services Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 Samsung Biologics Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Immunohistochemistry (IHC) Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Immunohistochemistry (IHC) Services by Company Revenue
  3.2.2 Top 3 Immunohistochemistry (IHC) Services Players Market Share in 2025
  3.2.3 Top 6 Immunohistochemistry (IHC) Services Players Market Share in 2025
3.3 Immunohistochemistry (IHC) Services Market: Overall Company Footprint Analysis
  3.3.1 Immunohistochemistry (IHC) Services Market: Region Footprint
  3.3.2 Immunohistochemistry (IHC) Services Market: Company Product Type Footprint
  3.3.3 Immunohistochemistry (IHC) Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Immunohistochemistry (IHC) Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Immunohistochemistry (IHC) Services Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Immunohistochemistry (IHC) Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Immunohistochemistry (IHC) Services Market Forecast by Application (2027-2032)

6 NORTH AMERICA

6.1 North America Immunohistochemistry (IHC) Services Consumption Value by Type (2021-2032)
6.2 North America Immunohistochemistry (IHC) Services Market Size by Application (2021-2032)
6.3 North America Immunohistochemistry (IHC) Services Market Size by Country
  6.3.1 North America Immunohistochemistry (IHC) Services Consumption Value by Country (2021-2032)
  6.3.2 United States Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  6.3.3 Canada Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  6.3.4 Mexico Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)

7 EUROPE

7.1 Europe Immunohistochemistry (IHC) Services Consumption Value by Type (2021-2032)
7.2 Europe Immunohistochemistry (IHC) Services Consumption Value by Application (2021-2032)
7.3 Europe Immunohistochemistry (IHC) Services Market Size by Country
  7.3.1 Europe Immunohistochemistry (IHC) Services Consumption Value by Country (2021-2032)
  7.3.2 Germany Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  7.3.3 France Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  7.3.5 Russia Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  7.3.6 Italy Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC

8.1 Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Immunohistochemistry (IHC) Services Market Size by Region
  8.3.1 Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value by Region (2021-2032)
  8.3.2 China Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  8.3.3 Japan Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  8.3.4 South Korea Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  8.3.5 India Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  8.3.7 Australia Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)

9 SOUTH AMERICA

9.1 South America Immunohistochemistry (IHC) Services Consumption Value by Type (2021-2032)
9.2 South America Immunohistochemistry (IHC) Services Consumption Value by Application (2021-2032)
9.3 South America Immunohistochemistry (IHC) Services Market Size by Country
  9.3.1 South America Immunohistochemistry (IHC) Services Consumption Value by Country (2021-2032)
  9.3.2 Brazil Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  9.3.3 Argentina Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Immunohistochemistry (IHC) Services Market Size by Country
  10.3.1 Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value by Country (2021-2032)
  10.3.2 Turkey Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)
  10.3.4 UAE Immunohistochemistry (IHC) Services Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS

11.1 Immunohistochemistry (IHC) Services Market Drivers
11.2 Immunohistochemistry (IHC) Services Market Restraints
11.3 Immunohistochemistry (IHC) Services Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Immunohistochemistry (IHC) Services Industry Chain
12.2 Immunohistochemistry (IHC) Services Upstream Analysis
12.3 Immunohistochemistry (IHC) Services Midstream Analysis
12.4 Immunohistochemistry (IHC) Services Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES

Table 1. Global Immunohistochemistry (IHC) Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Immunohistochemistry (IHC) Services Consumption Value by Scale, (USD Million), 2021 & 2025 & 2032
Table 3. Global Immunohistochemistry (IHC) Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Immunohistochemistry (IHC) Services Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Immunohistochemistry (IHC) Services Consumption Value by Region (2027-2032) & (USD Million)
Table 6. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 7. Charles River Laboratories Major Business
Table 8. Charles River Laboratories Immunohistochemistry (IHC) Services Product and Solutions
Table 9. Charles River Laboratories Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Charles River Laboratories Recent Developments and Future Plans
Table 11. Labcorp Drug Development Company Information, Head Office, and Major Competitors
Table 12. Labcorp Drug Development Major Business
Table 13. Labcorp Drug Development Immunohistochemistry (IHC) Services Product and Solutions
Table 14. Labcorp Drug Development Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Labcorp Drug Development Recent Developments and Future Plans
Table 16. IQVIA Company Information, Head Office, and Major Competitors
Table 17. IQVIA Major Business
Table 18. IQVIA Immunohistochemistry (IHC) Services Product and Solutions
Table 19. IQVIA Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. ICON plc Company Information, Head Office, and Major Competitors
Table 21. ICON plc Major Business
Table 22. ICON plc Immunohistochemistry (IHC) Services Product and Solutions
Table 23. ICON plc Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. ICON plc Recent Developments and Future Plans
Table 25. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 26. Eurofins Scientific Major Business
Table 27. Eurofins Scientific Immunohistochemistry (IHC) Services Product and Solutions
Table 28. Eurofins Scientific Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Eurofins Scientific Recent Developments and Future Plans
Table 30. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 31. Thermo Fisher Scientific Major Business
Table 32. Thermo Fisher Scientific Immunohistochemistry (IHC) Services Product and Solutions
Table 33. Thermo Fisher Scientific Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Thermo Fisher Scientific Recent Developments and Future Plans
Table 35. Bio-Techne Company Information, Head Office, and Major Competitors
Table 36. Bio-Techne Major Business
Table 37. Bio-Techne Immunohistochemistry (IHC) Services Product and Solutions
Table 38. Bio-Techne Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Bio-Techne Recent Developments and Future Plans
Table 40. NeoGenomics Laboratories Company Information, Head Office, and Major Competitors
Table 41. NeoGenomics Laboratories Major Business
Table 42. NeoGenomics Laboratories Immunohistochemistry (IHC) Services Product and Solutions
Table 43. NeoGenomics Laboratories Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. NeoGenomics Laboratories Recent Developments and Future Plans
Table 45. HistoCyte Laboratories Company Information, Head Office, and Major Competitors
Table 46. HistoCyte Laboratories Major Business
Table 47. HistoCyte Laboratories Immunohistochemistry (IHC) Services Product and Solutions
Table 48. HistoCyte Laboratories Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. HistoCyte Laboratories Recent Developments and Future Plans
Table 50. Histowiz Company Information, Head Office, and Major Competitors
Table 51. Histowiz Major Business
Table 52. Histowiz Immunohistochemistry (IHC) Services Product and Solutions
Table 53. Histowiz Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Histowiz Recent Developments and Future Plans
Table 55. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 56. WuXi AppTec Major Business
Table 57. WuXi AppTec Immunohistochemistry (IHC) Services Product and Solutions
Table 58. WuXi AppTec Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. WuXi AppTec Recent Developments and Future Plans
Table 60. Provitro Company Information, Head Office, and Major Competitors
Table 61. Provitro Major Business
Table 62. Provitro Immunohistochemistry (IHC) Services Product and Solutions
Table 63. Provitro Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Provitro Recent Developments and Future Plans
Table 65. NICHIREI BIOSCIENCES INC. Company Information, Head Office, and Major Competitors
Table 66. NICHIREI BIOSCIENCES INC. Major Business
Table 67. NICHIREI BIOSCIENCES INC. Immunohistochemistry (IHC) Services Product and Solutions
Table 68. NICHIREI BIOSCIENCES INC. Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. NICHIREI BIOSCIENCES INC. Recent Developments and Future Plans
Table 70. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 71. Samsung Biologics Major Business
Table 72. Samsung Biologics Immunohistochemistry (IHC) Services Product and Solutions
Table 73. Samsung Biologics Immunohistochemistry (IHC) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Samsung Biologics Recent Developments and Future Plans
Table 75. Global Immunohistochemistry (IHC) Services Revenue (USD Million) by Players (2021-2026)
Table 76. Global Immunohistochemistry (IHC) Services Revenue Share by Players (2021-2026)
Table 77. Breakdown of Immunohistochemistry (IHC) Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Immunohistochemistry (IHC) Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 79. Head Office of Key Immunohistochemistry (IHC) Services Players
Table 80. Immunohistochemistry (IHC) Services Market: Company Product Type Footprint
Table 81. Immunohistochemistry (IHC) Services Market: Company Product Application Footprint
Table 82. Immunohistochemistry (IHC) Services New Market Entrants and Barriers to Market Entry
Table 83. Immunohistochemistry (IHC) Services Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Immunohistochemistry (IHC) Services Consumption Value (USD Million) by Type (2021-2026)
Table 85. Global Immunohistochemistry (IHC) Services Consumption Value Share by Type (2021-2026)
Table 86. Global Immunohistochemistry (IHC) Services Consumption Value Forecast by Type (2027-2032)
Table 87. Global Immunohistochemistry (IHC) Services Consumption Value by Application (2021-2026)
Table 88. Global Immunohistochemistry (IHC) Services Consumption Value Forecast by Application (2027-2032)
Table 89. North America Immunohistochemistry (IHC) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 90. North America Immunohistochemistry (IHC) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 91. North America Immunohistochemistry (IHC) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 92. North America Immunohistochemistry (IHC) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 93. North America Immunohistochemistry (IHC) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 94. North America Immunohistochemistry (IHC) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 95. Europe Immunohistochemistry (IHC) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 96. Europe Immunohistochemistry (IHC) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 97. Europe Immunohistochemistry (IHC) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 98. Europe Immunohistochemistry (IHC) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 99. Europe Immunohistochemistry (IHC) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 100. Europe Immunohistochemistry (IHC) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 104. Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 105. Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value by Region (2027-2032) & (USD Million)
Table 107. South America Immunohistochemistry (IHC) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 108. South America Immunohistochemistry (IHC) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 109. South America Immunohistochemistry (IHC) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 110. South America Immunohistochemistry (IHC) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 111. South America Immunohistochemistry (IHC) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 112. South America Immunohistochemistry (IHC) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 114. Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 115. Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 116. Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 117. Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Global Key Players of Immunohistochemistry (IHC) Services Upstream (Raw Materials)
Table 120. Global Immunohistochemistry (IHC) Services Typical Customers

LIST OF FIGURES

Figure 1. Immunohistochemistry (IHC) Services Picture
Figure 2. Global Immunohistochemistry (IHC) Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Immunohistochemistry (IHC) Services Consumption Value Market Share by Type in 2025
Figure 4. Biomarker Detection IHC Services
Figure 5. Protein Expression Analysis IHC Services
Figure 6. Tumor Tissue IHC Services
Figure 7. Normal Tissue IHC Services
Figure 8. Animal Model Tissue IHC Services
Figure 9. Global Immunohistochemistry (IHC) Services Consumption Value by Scale, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Immunohistochemistry (IHC) Services Consumption Value Market Share by Scale in 2025
Figure 11. Small-Scale IHC Service (<50 Slides)
Figure 12. Medium-Scale IHC Service (50–500 Slides)
Figure 13. Large-Scale IHC Service (>500 Slides)
Figure 14. Global Immunohistochemistry (IHC) Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 15. Immunohistochemistry (IHC) Services Consumption Value Market Share by Application in 2025
Figure 16. Drug Discovery Research Picture
Figure 17. Oncology Research Picture
Figure 18. Clinical Biomarker Validation Picture
Figure 19. Pathology Diagnosis Picture
Figure 20. Toxicology Studies Picture
Figure 21. Others Picture
Figure 22. Global Immunohistochemistry (IHC) Services Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Immunohistochemistry (IHC) Services Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Immunohistochemistry (IHC) Services Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Immunohistochemistry (IHC) Services Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Immunohistochemistry (IHC) Services Consumption Value Market Share by Region in 2025
Figure 27. North America Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Immunohistochemistry (IHC) Services Revenue Share by Players in 2025
Figure 34. Immunohistochemistry (IHC) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Immunohistochemistry (IHC) Services by Player Revenue in 2025
Figure 36. Top 3 Immunohistochemistry (IHC) Services Players Market Share in 2025
Figure 37. Top 6 Immunohistochemistry (IHC) Services Players Market Share in 2025
Figure 38. Global Immunohistochemistry (IHC) Services Consumption Value Share by Type (2021-2026)
Figure 39. Global Immunohistochemistry (IHC) Services Market Share Forecast by Type (2027-2032)
Figure 40. Global Immunohistochemistry (IHC) Services Consumption Value Share by Application (2021-2026)
Figure 41. Global Immunohistochemistry (IHC) Services Market Share Forecast by Application (2027-2032)
Figure 42. North America Immunohistochemistry (IHC) Services Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Immunohistochemistry (IHC) Services Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Immunohistochemistry (IHC) Services Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Immunohistochemistry (IHC) Services Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Immunohistochemistry (IHC) Services Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Immunohistochemistry (IHC) Services Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 52. France Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Immunohistochemistry (IHC) Services Consumption Value Market Share by Region (2021-2032)
Figure 59. China Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 62. India Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Immunohistochemistry (IHC) Services Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Immunohistochemistry (IHC) Services Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Immunohistochemistry (IHC) Services Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Immunohistochemistry (IHC) Services Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Immunohistochemistry (IHC) Services Consumption Value (2021-2032) & (USD Million)
Figure 76. Immunohistochemistry (IHC) Services Market Drivers
Figure 77. Immunohistochemistry (IHC) Services Market Restraints
Figure 78. Immunohistochemistry (IHC) Services Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Immunohistochemistry (IHC) Services Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source